Professor Michael Heinrich to join Cambridge Nutraceuticals’ Scientific Review Board

Professor Michael Heinrich to join Cambridge Nutraceuticals’ Scientific Review Board

Cambridge Nutraceuticals, which develops and sells supplements with scientific evidence of effectiveness and bioavailability directly to consumers, is delighted to announce that Professor Michael Heinrich is joining its scientific review board with effect from 1January 2018.

Michael Heinrich is a Professor of Ethnopharmacology and Medicinal Plant Research (Pharmacognosy) at University College London (‘UCL’) School of Pharmacy and was until recently the head of the research cluster there.  He currently serves as the joint chair of UCL’s Research Ethics Committee.

Professor Heinrich is author of over 300 published peer-reviewed papers, and is widely cited and recognised as an expert in the field of medicinal plant research.  His key areas of interest include the prevention and early stage management of diabetes (metabolic syndrome) and cancer chemoprevention based on the use of traditional medicines as well as best practice in the supply of herbal medical products / botanicals (value chains).

He joins the scientific review board of Cambridge Nutraceuticals to help the business in its review and assessment of clinically evaluated supplements and food extracts that have meaningful benefits for consumers.

Professor Heinrich said, “I am delighted to be joining such a dynamic company that is so passionate about delivering clinically proven supplements.  I look forward to adding my experience to the team.”

Tim Dye, Executive Chairman of Cambridge Nutraceuticals said, “I have known Michael and his work for many years.  He is a true expert with an enviable breadth of knowledge.  I am delighted to welcome him to Cambridge Nutraceuticals.”




RSS feed